ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 09:01 am Sale | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ADAGE CAPITAL PARTNERS GP L.L.C. | 40,000 2.030% | -79,680 (-66.58%) | Filing |
| 2021-02-11 07:31 am Purchase | 2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ADAGE CAPITAL PARTNERS GP L.L.C. | 119,680 6.240% | 60,936 (+103.73%) | Filing |